Patterns of cellular immunity associated with experimental infection with rDEN2Δ30 (Tonga/74) support its suitability as a human dengue virus challenge strain

Alba Grifoni, Michael Angelo, John Sidney, Sinu Paul, Bjoern Peters, Aruna D. de Silva, Elizabeth Phillips, Simon Mallal, Sean A. Diehl, Jason Botten, Jonathan Boyson, Beth D. Kirkpatrick, Stephen S. Whitehead, Anna P. Durbin, Alessandro Sette, Daniela Weiskopf

Research output: Contribution to journalArticle

Abstract

A deletion variant of the dengue virus (DENV) serotype 2 (DENV2) Tonga/74 strain lacking 30 nucleotides from its 3= untranslated region (rDEN2Δ30) has previously been established for use in a controlled human DENV challenge model. To evaluate if this model is appropriate for the derivation of correlates of protection for DENV vaccines on the basis of cellular immunity, we wanted to compare the cellular immune response to this challenge strain to the response induced by natural infection. To achieve this, we predicted HLA class I- and class II-restricted peptides from rDEN2Δ30 and used them in a gamma interferon enzyme-linked immunosorbent spot assay to interrogate CD8+ and CD4+ T cell responses in healthy volunteers infected with rDEN2Δ30. At the level of CD8 responses, vigorous ex vivo responses were detected in approximately 80% of donors. These responses were similar in terms of the magnitude and the numbers of epitopes recognized to the responses previously observed in peripheral blood mononuclear cells from donors from regions where DENV is hyperendemic. The similarity extended to the immunodominance hierarchy of the DENV nonstructural proteins, with NS3, NS5, and NS1 being dominant in both donor cohorts. At the CD4 level, the responses to rDEN2Δ30 vaccination were less vigorous than those to natural DENV infection and were more focused on nonstructural proteins. The epitopes recognized following rDEN2Δ30 infection and natural infection were largely overlapping for both the CD8 (100%) and CD4 (85%) responses. Finally, rDEN2Δ30 induced stronger CD8 responses than other, more attenuated DENV isolates.

Original languageEnglish (US)
Article numbere02133-16
JournalJournal of virology
Volume91
Issue number8
DOIs
StatePublished - Apr 1 2017

Keywords

  • Dengue virus
  • Human challenge model
  • T cells
  • Vaccine

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Fingerprint Dive into the research topics of 'Patterns of cellular immunity associated with experimental infection with rDEN2Δ30 (Tonga/74) support its suitability as a human dengue virus challenge strain'. Together they form a unique fingerprint.

  • Cite this

    Grifoni, A., Angelo, M., Sidney, J., Paul, S., Peters, B., de Silva, A. D., Phillips, E., Mallal, S., Diehl, S. A., Botten, J., Boyson, J., Kirkpatrick, B. D., Whitehead, S. S., Durbin, A. P., Sette, A., & Weiskopf, D. (2017). Patterns of cellular immunity associated with experimental infection with rDEN2Δ30 (Tonga/74) support its suitability as a human dengue virus challenge strain. Journal of virology, 91(8), [e02133-16]. https://doi.org/10.1128/JVI.02133-16